Press ReleaseHyundai Motor Group Celebrates 20 Years of Driving Innovation at the Hyundai California Proving Ground Milestone reaffirms Hyundai Motor Group’s commitment to safety, quality, design, and performance… CISION PRNewswireFebruary 13, 2025
Restore Vision Announces First Patient Dosed in Phase I/II Clinical Trial of RV-001 for Gene-Agnostic Retinitis Pigmentosa The first optogenetic "Chimeric Rhodopsin" gene therapy tested in humans. RV-001 starting… CISION PRNewswireFebruary 13, 2025
Aker Horizons ASA: Fourth-quarter results 2024 FORNEBU, Norway, Feb. 13, 2025 /PRNewswire/ — Aker Horizons ASA (OSE: AKH), a developer… CISION PRNewswireFebruary 13, 2025
Cloud4C Secures Dual AI Specializations on Microsoft Azure, Strengthening AI Capabilities SINGAPORE, Feb. 13, 2025 /PRNewswire/ — Cloud4C, a global leader in AI-driven… CISION PRNewswireFebruary 13, 2025
Hugel achieves record net sales, profit, net income in 2024 – The company reports KRW373.0 billion in net sales, KRW166.3 billion in… CISION PRNewswireFebruary 13, 2025
Press ReleaseDAAN Biotherapeutics Signs Antibody Exclusive Licensing Agreement with LigaChem Biosciences for ADC (Antibody-Drug Conjugate) Therapeutic Development SEOUL, South Korea, Feb. 13, 2025 /PRNewswire/ — DAAN Biotherapeutics, a leading… CISION PRNewswireFebruary 13, 2025
Press ReleaseWoolpert Welcomes Head of Strategic Growth, Asia-Pacific Susie Henderson The accomplished global business executive will oversee the firm’s strategic growth initiatives… CISION PRNewswireFebruary 13, 2025
Alphamab Oncology Announces the First Patient Dosed in a Phase III Clinical Study for Ovarian Cancer of Anti-HER2 Bispecific ADC JSKN003 SUZHOU, China, Feb. 13, 2025 /PRNewswire/ — Alphamab Oncology (stock code: 9966.HK)… CISION PRNewswireFebruary 13, 2025
